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BAK is a pro-apoptotic BCL-2 protein 
that forms toxic mitochondrial pores in 
response to cellular stress. A membrane-
embedded protein historically refractory 
to recombinant expression in full-length 
form, BAK plays it close to the vest. We 
recently produced monomeric, full-length 
BAK (FL-BAK) for the first time,1 provid-
ing new opportunities to interrogate its 
activation mechanism as compared with 
its close homolog BAX. Unlike BAX, sol-
uble FL-BAK auto-translocates to isolated 
mitochondria, preferring the membrane 
environment, consistent with the rela-
tive subcellular distributions of BAX and 
BAK in vivo. FL-BAK translocation did 
not permeabilize the mitochondria unless 
a triggering ligand was present. Indeed, 
we measured direct, sequence-dependent 
interactions between FL-BAK and an acti-
vating BH3 helix. The BH3-only protein 
tBID, or a hydrocarbon-stapled version of 
its BH3 helix, oligomerized FL-BAK in 
the absence of any other factors, defini-
tively demonstrating a direct activation 
mechanism.1 Applying photoreactive BH3 
helices and MS analysis, we mapped the 
trigger site for direct BAK activation to 
its canonical pocket at the C-terminal 
face, whereas the same ligands crosslinked 
to BAX at the novel N-terminal trig-
ger site and, upon allosteric release of its 
C-terminal helix, to the exposed canonical 
pocket as well.1 Our analyses suggest that 
activating BH3 interactions at the canoni-
cal pocket in the context of the mitochon-
drial membrane may represent a common 
mechanism for propelling the activation 
and oligomerization of BAK/BAX, with 
the N-terminal triggering mechanism 
of cytosolic BAX representing a unique 
afferent step required to initiate its acti-
vation and mitochondrial translocation. 
With new rules of the game continually 
revealed, the competitive interplay among 
BCL-2 family members has made for an 
exciting spectator sport that pits cellular 
life against cellular death.
BCL-2 proteins regulate apopto-
sis through complex and strategic plays 
among team members. On offense are 
BAK and BAX, two formidable teammates 
that, when activated by BH3 stress signal-
ing, spring into action and score, forming 
a game-ending victory circle at the mito-
chondrial outer membrane—the end zone 
of the apoptotic pathway. The defense is 
comprised of nimble players like BCL-2 
and MCL-1 that block the activated forms 
of BAK/BAX, stopping the death clock to 
keep the game alive. In large part, which 
team wins depends on who is carrying 
the ball, represented by the critical BH3-
only proteins, an elite subgroup of pro-
apoptotic BCL-2 family players whose 
only weapon for interaction is their single 
BH3 helix. Fortunately, during stressful 
circumstances, the quarterback has an 
arsenal of diverse BH3s to launch, some of 
which have the dual capacity to engage the 
offense and defense, further complicating 
the action.
The first structural studies of a BCL-2 
protein created a player card for anti-
apoptotic BCL-XL, highlighting how its 
α-helices fold to form a surface pocket 
for intercepting the BH3 helix of pro-
apoptotic members.2 The interaction 
paradigm for how anti-apoptotics play 
defense was revealed: intercept the BH3 
killer domain of the signaling BH3-only 
proteins (Fig. 1, Defensive play 1) and 
grab onto that of the activated forms of 
BAK/BAX for the block (Fig. 1, Defensive 
play 2). Fake passes from the quarterback 
(or drugs that neutralize the anti-apop-
totic pocket), disorient the defensive play-
ers, liberating the offense to score a win for 
the home team (Fig. 1, Offensive play 1). 
Historically, knowledge of anti-apoptotic 
tactics for defending against cell death has 
exceeded our understanding of how the 
offense, represented by BAK/BAX, launch 
into action in the first place, making them 
rather controversial players.
It has been a challenge to study BCL-2 
players in their full-length form, especially 
those like BAK that reside in the mito-
chondrial end zone. Preferring to play the 
cytosolic field, BAX has been amenable 
to analysis in full-length form, reveal-
ing many operational secrets, including 
its structure, transformational responses 
to direct engagement by BH3 domains 
and even localization of the BH3 point-
of-contact for initiating BAX’s sprint to 
the end zone3 (Fig. 1, Offensive play 2). 
Some officials have long heralded a direct 
activation strategy for BAX4 and BAK,5 
although a group of highly regarded ref-
erees questioned the maneuver, if not dis-
missed it outright by throwing a penalty 
flag.6 However, the game charged on, and 
the direct activation play became such 
a crowd pleaser that even the naysayers 
ultimately joined the chorus of cheering 
fans.7 Lurking at the end zone to catch 
the Hail Mary pass, BAK has avoided the 
spotlight, but biochemical and structural 
analyses of its truncated and full-length 
forms have now revealed that it too is a 
target for direct activation, faking out 
the defense by using the traditional inter-
action site for anti-apoptotic blockade 
of BH3 domains as its very own trigger 
site1,8 (Fig. 1, Offensive play 3)! Indeed, 
once BAX reaches the mitochondrial end 
zone—its canonical site now available for 
engagement after allosteric release of the 
occupying C-terminal helix during upfield 
play3 (Fig. 1, see Offensive play 2)—it 
may also engage in BH3-in-canonical 1334  Cell Cycle  Volume 12 issue 9
groove action to secure the oligomeric 
touchdown.1,7 With these game-changing 
new surfaces for direct BAK and BAX 
activation revealed, coaches are already 
pondering whether new pharmacologic 
approaches might be permissible to power 
up their offense and stack the deck against 
notorious opponents like cancer, whose 
defenses must be overcome by any means 
necessary.
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(defensive play 2, block). However, when distracted by a fake pass from the quarterback, a disoriented defense can inadvertently release its grip on 
activated BaK or BaX, liberating the once-trapped offensive players to score (offensive play 1, pump fake). the offensive running back, BaX, plays 
the cytosolic field and upon catching an activating BH3 helix in its N-terminal α1/α6 pocket, deploys its C-terminal helix and charges to the end zone 
(offensive play 2, forward pass). BaK, with its C-terminal helix already firmly planted in the end zone, fakes out the defense by catching the Hail Mary 
activating BH3 helix in its C-terminal canonical pocket (a move that activated BaX, upon reaching the end zone, may also have in its playbook), catalyz-
ing the formation of an oligomeric victory circle in celebration of the game-ending touchdown (offensive play 3, Hail Mary pass). Figure acknowledg-
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